Helpline
+91 8892 555 000
Email : contactus@ordindia.in

Gov’t to reduce burden for rare disease patients

By Jung Hae-myoung Starting next year, more patients battling rare diseases will pay less for their medical expenses, as 100 disorders have been newly added to the government’s subsidy list,...

Read More

Why Farber Disease May Be Misdiagnosed as Juvenile Idiopathic Arthritis

Farber disease is a rare, autosomal-recessive disorder caused by a mutation in the acid ceramidase gene, which leads to accumulation of sphingolipids in various tissues.1 It typically presents with a combination...

Read More

NRI techies master the art of giving to the motherland

Washington DC: Call it the “Art of Giving to the motherland, the techies’ way”. After building America with their brains and grit, the Indian techies are going all out to...

Read More

Why the birth of first gene-edited babies in China has got the whole world worried and alarmed

Chinese scientist He Jiankui speaks at the Second International Summit on Human Genome Editing in Hong Kong on November 28, 2018. The announcement of the birth of babies with edited...

Read More

Kids die of rare diseases, as govt struggles fund shortage

The ministry of health and family welfare that is getting continuous requests from patient organizations for funds has reached out to the finance ministry seeking financial help. New Delhi: Several...

Read More

A rare-disease entrepreneur follows an unconventional drug development path

In 2012, Ethan Perlstein challenged the academic status quo. Now as CEO of the start-up Perlara, can he do the same for the biotech industry? In 2012, molecular biologist Ethan...

Read More

A comparative study of orphan drugs in US, EU & India

Today, more than 5,000 diseases are catalogued as “rare” by the scientific community, so long as they affect small sections of population. The drugs used for the treatment of rare...

Read More

Experts raise concern over delay in implementation of rare diseases treatment policy

Health experts Wednesday highlighted the need for an immediate call-to-action for the implementation of the National Policy for Treatment of Rare Diseases, stating that the patients were suffering and losing...

Read More

After new rare diseases policy, govt incentives needed for finding cures

Medical experts say India also needs an orphan drug policy to provide incentives to pharmaceutical companies to innovate and manufacture drugs for rare diseases...

Read More

Delhi: 20-month-old refused Gaucher treatment due to treatment cost

For Maqsood Alam, saving his 20-month-old son, Ahsan, has become a personal challenge after he lost three of his children to Gaucher disease in the past. Ahsan, born in February...

Read More

Highslide for Wordpress Plugin